BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...
BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...
Together, the companies intend to develop new software capabilities within BD flow cytometer instrument software to be compatible with Biosero’s Green Button Go® software, as well as jointly ...
Our BD 2025 strategy has transformed the company into a faster-growing, more profitable organization positioned at the forefront of long-term growth ...
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...
Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...
(MENAFN- PR Newswire) Together, the companies intend to develop new software capabilities within BD flow cytometer instrument software to be compatible with Biosero's Green Button Go® software ...